Member Info for gameangler

For info:
https://seekingalpha.com/article/4290742-novelions-8_1-percent-stake-amryt-worth-1_50-share?dr=1

Looks like Chapter 11 court confirmation is delayed by ongoing objections:
https://www.inforuptcy.com/filings/nysbke_293161-1-19-bk-11632-aegerion-pharmaceuticals-inc

https://www.brrmedia.co.uk/broadcasts/5d6cfe242760173908009455/ariana-rescoures-kiziltepe-drilling-update

https://www.youtube.com/watch?v=UnpGpdclQUo

Disappointing waffle

https://seekingalpha.com/pr/17601133-novelion-therapeutics-announces-anticipated-late-filing-quarterly-report-form-10-q-quarter

https://www.edisongroup.com/publication/strength-through-diversification/24623/

https://www.edisongroup.com/wp-content/uploads/2019/07/IQE-Demonstrating-resilience-to-supply-chain-shifts-4.pdf

The legendary Resources investor Rick Rule giving wise advice about investing in companies,
listen from 19 mins
https://www.youtube.com/watch?v=Kr3IM1vFEXY&feature=youtu.be

https://*****boom.com/posts/7317330-block-energy-xtract-resources-and-cadence-minerals

Not sure if this article from 1st July has been posted .
There is a video interview with Colin about re. Zinc Star
https://www.proactiveinvestors.co.uk/companies/news/223138/galileo-resources-targets-mining-permit-for-star-zinc-after-initial-inferred-resource-223138.html

With Sable starting processing at 20t/hr rising in 2yrs to 40t/hr they’re targeting 8,000t of zinc metal.
We can assume their Kabwe tailings run of the mill grade is 8% Zn. This is the proposed cut off grade for direct shipping ore from Star Zinc. GLR proposed to ship 72,000t over 6yrs ie 12,000t/pa of zinc metal at an av grade of 21%.
It must be much more profitable to process the high grade from Zinc Star as process costs must have a high percentage fixed cost.
To me this looks compelling. Expect aan interim placing but given the value of the asset I am willing to accept that.

https://audioboom.com/posts/7288064-safestay-botswana-diamonds-europa-metals-and-glen-goodman-on-crypto

https://www.proactiveinvestors.co.uk/companies/stocktube/13726/summit-therapeutics--taking-leadership-role--in-development-of-new-antibiotics-13726.html

In HL had two accounts ( SIPP & ISA) with 5k in each.
I applied for another 5k in each and got 100% so happy to reduce my average cost to 80p.
For patient investors, this share has the potential to be highly rewarding.

https://seekingalpha.com/article/4240320-novelion-therapeutics-recent-licensing-deal-reignites-stock-debating-buy

Recent article posted 12/02/19 on Novelion after closing up front payment of $25m for JUXTAPID exclusivity commercialisation rights in Japan. It also included rights to milestone payments and quarterly 22.5% royalties.

This was more than market cap of $23m at the time.(98% off it's 2013 high)

Novelion and Aegerion appeared to have an oversized debt of $412m with little cash.There was also an outstanding sum of $32.8m on the $40m fine by DoJ/SEC.

Expected revenues for 2018 were $130-140m . The forecast generated revenues for 2019 were $145-160m.

Some interesting times to come for Amryt shareholders.

https://www.globenewswire.com/news-release/2019/05/21/1829250/0/en/Novelion-Therapeutics-Announces-Subsidiary-Aegerion-Pharmaceuticals-to-Recapitalize-Through-Court-Supervised-Process-In-Which-Amryt-Pharma-Plc-Will-Acquire-100-of-Reorganized-Stock.html

This is in Africa.
There can be layers of bureaucracy whose wheels need lubricating.
Its having the right contacts to achieve this.

For info some newer investors may not be aware of BMR period history of development.

http://www.bmrplc.com/kashitu-geological-exploration.php

Good start are RNS posts see : http://www.lse.co.uk/share-regulatory-news.asp?shareprice=BMR

13-06-16 Kashitu

06-12-16 General

29-12-16 Zinc Star

10-01-17 Kashitu

31-03-17 Kashitu/Zinc Star

03-05-17 Kashitu

28-10-17 Kashitu

23-06-17 Kashitu

23-10-17 Kashitu

28-12-17 Kashitu

BMR completed 450 1m(max) deep hand augered samples of alluvial ground which were checked by XRF analyser with random assayed samples.They intended to move their sampling to adjacent lower areas run off and to start drilling to investigate the depths and extend of the high grade mineralised area that had been found. This never happened as they had insufficient funds.
A significant sum of investigation money needs spending to identify the resource insitu at Kishitu.

CB said at his recent UK Investor Show presentation that the recent cash raise was for developing Zinc Start to have ore ready to sell at the end of the year, subject to receiving a small scale mining licence ( not a necessarily a formality).
He also said a cash raise for drilling Kishitu will be needed, and whilst not giving a time or value, he appeared keen to get on with it. Probably lining up some new investors as we speak. With JLP signed to an off-take agreement , he could dangle some attractive potential earnings in front of them.

The current arc of increasing political instability across North Africa may be a concern for potential investors.

SDX operates in two of the relatively more stable states, but the current price appears to be reflecting fears about something. Though there seems to be general low valuations across a range some pretty good AIM shares.

Also JC interview on V_O_X markets today on Thorny River